Something shifted hard in early 2026. The March Novo Nordisk settlement pushed a lot of telehealth brands off compounded semaglutide and toward branded versions, which cost multiples more. On top of that, the FDA sent warning letters to more than 30 compounding firms. The market got smaller, faster, and more expensive for a lot of people who had been managing their weight on cash-pay compounded medications.
Tirzepatide, though, has stayed more accessible. Compounded versions remain available through legitimate 503A pharmacies while shortage designations hold. That window won’t last forever, but right now there are real programs offering it at prices that don’t require insurance gymnastics.
Here’s what I looked at before building this list.
What I Looked At
Price: Monthly all-in cost, not just the teaser rate. Pharmacy transparency: Is there a named, verifiable pharmacy? Speed: How fast does a physician review and how fast does medication ship? Monitoring: Is there any real clinical oversight or just a rubber-stamp consult? Reach: How many states does the program actually serve?
I did not score anyone on vague “support quality” claims or influencer partnerships. None of these are FDA-approved medications. Every program here uses compounded tirzepatide or refers you to branded options where noted.
1. HealthRX
Compounded tirzepatide starting at $149 per month is the number that puts HealthRX at the top of this list. That’s a genuine cash price, not a first-month discount that resets. Medication is dispensed through Manifest Pharmacy in Greer, South Carolina, a 503A facility operating under USP-797 standards with lot-to-door tracking on every vial. HealthRX holds a LegitScript certification (cert 50087439), which is a public, independently verifiable credential that takes real compliance work to earn. A board-certified physician reviews your intake within roughly 24 hours, and overnight shipping to all 50 states is included at no extra charge. For most people comparing cash-pay tirzepatide options right now, the combination of named pharmacy, overnight delivery, and sub-$150 entry pricing is hard to beat.
2. FormBlends
FormBlends costs more upfront. Tirzepatide runs around $349 per vial, and semaglutide around $299. So why is it on this list? Because it publishes actual purity test results for each product, including HPLC purity percentages, mass spec identity confirmation, and endotoxin and sterility data with named numbers attached. Most GLP-1 telehealth platforms don’t share any of that. FormBlends also carries a broader peptide catalog covering recovery, longevity, and cognitive health under the same clinician oversight model, which makes it worth a look if you want one provider for more than weight loss alone. It ships to 47 states, not 50, and the price point is higher than HealthRX’s entry pricing. But if published batch testing matters to you, or you want GLP-1s alongside other peptide protocols from a single prescribing team, FormBlends earns a real spot here.
3. Mochi Health
Mochi keeps compounded tirzepatide at around $199 per month and compounded semaglutide at around $99. What separates it from a lot of budget options is that the clinicians on staff carry board certification in obesity medicine specifically. That’s not the same as a general practitioner ticking a checkbox. Mochi tends to include more touchpoints per month than platforms that treat the consult as a one-time event. Not the cheapest on this list, but the clinical depth justifies the gap for people who want more than a script and a tracking app.
4. Henry Meds
Henry Meds operates as a straightforward cash-pay compounded service, with first-month pricing often landing between $179 and $249 depending on the medication and dose. Shipping runs 24 to 72 hours. The monitoring is lighter than what you get at Mochi, which suits people who have already been on a GLP-1 regimen and know what they’re doing, but may not be the best fit for someone just starting out.
5. MEDVi
MEDVi’s first-month rate comes in around $179 for compounded options, with no long-term contract required. That no-contract structure matters. Some programs lock you into quarterly or annual commitments before you know whether the medication works for you. MEDVi lets you test before committing at scale.
6. PlushCare
PlushCare takes a different angle. The platform membership is around $19.99 per month, and the focus is on branded medications with insurance billing. If you have coverage that might include Zepbound or another branded GLP-1, PlushCare’s prior-authorization support and same-day appointment availability make it one of the more practical paths to getting branded tirzepatide at a manageable cost. Not a compounded option, but a strong pick for the insured patient.
7. WeightWatchers Clinic
WeightWatchers Clinic charges roughly $74 per month for the program layer, with medications billed separately. The brand recognition brings built-in accountability tools and a community infrastructure that purely medical platforms don’t offer. The total monthly cost will be higher once you add meds, but for someone who wants behavioral support woven into the same subscription, it’s a reasonable bundle.
How to Choose
Match the program to your actual situation. If cash price and pharmacy accountability are your main criteria, the top of this list handles both. If you want published purity testing or a broader peptide catalog from one provider, look at FormBlends. If you carry insurance that might cover branded tirzepatide, PlushCare or Hims and Hers are worth pricing out before defaulting to compounded.
One honest caution: compounded tirzepatide is not FDA-approved, shortage designations can change, and any program promising clinical results beyond what the trial literature supports is overselling. The SURMOUNT-1 trial showed roughly 21% body weight reduction over 72 weeks with tirzepatide. That’s the benchmark, achieved under controlled conditions. Real-world results vary. Talk to your own doctor before starting anything here.
Common Questions
How long will compounded tirzepatide actually stay legal to prescribe?
No one can give a firm date. Compounded tirzepatide is permitted while the FDA maintains a shortage designation for the branded version. Shortage status is reviewed periodically and can change with little public warning. Most programs will pivot to branded options if the window closes, but prices would rise substantially. Check FDA shortage listings directly before committing to a long-term plan.
Does HealthRX’s $149 price hold after the first month, or is it a promotional rate?
Based on publicly available pricing, $149 is stated as the ongoing monthly cash price rather than an introductory offer. That said, prices across all these programs can change as shortage designations shift and pharmacy costs fluctuate. Confirm the current rate directly with HealthRX before assuming it stays flat through a full course of treatment.
Is FormBlends’ batch testing actually meaningful, or is it just marketing?
Published HPLC purity percentages, mass spec identity confirmation, and endotoxin and sterility results with real numbers attached are substantively more than most platforms offer. Whether any specific batch meets your personal threshold for quality assurance is your call, but the data points FormBlends publishes are the same categories independent compounding labs use for professional verification.
Which of these programs makes the most sense if I already have insurance and want branded Zepbound?
PlushCare is the clearest fit. Its model is built around insurance billing and prior-authorization support for branded medications, not compounded alternatives. The $19.99 monthly membership cost is low enough that even a single successful prior-auth for Zepbound covers it many times over. Mochi also works with some insurance plans, but PlushCare’s same-day appointment availability gives it a practical edge for getting the paperwork moving quickly.
Can I switch programs mid-treatment without starting the titration schedule over?
Generally yes, but it depends on the receiving program’s intake process. Most telehealth platforms will accept prior dosing history during the clinical intake questionnaire and have their prescribing physician carry your current dose forward. Bring documentation of your dose and duration. Programs with board-certified obesity medicine clinicians, like Mochi, are more likely to honor a mid-protocol transfer without defaulting you back to the starting dose.
Sources
- FDA compounding warning letters and shortage status updates (FDA.gov, 2025-2026)
- SURMOUNT-1 trial results, published in *The New England Journal of Medicine*, 2022
- STEP 1 semaglutide trial, *The New England Journal of Medicine*, 2021
- LegitScript certification database (LegitScript.com)
- Coverage of the Novo Nordisk settlement terms and timeline, March 2026 (Reuters, STAT News)
- Eli Lilly orforglipron announcement and LillyDirect pricing, April 2026 (Lilly press release)
